OncLive® Scientific Interchange and Workshop Podcast Series: Updates in the Management of HER2+ Breast Cancer

home / scientific-interchange-and-workshop / onclive-scientific-interchange-and-workshop-podcast-series-updates-in-the-management-of-her2-bre

In this 3-part podcast series from a previously recorded event, Komal Jhaveri, MD, is joined by community medical oncologists from New York and New Jersey to discuss the remaining unmet needs in the management of HER2-positive breast cancer, and the treatment of early and advanced stage HER2-positive breast cancer.

Unmet Needs in the Treatment of HER2-Positive Breast Cancer

EP. 1: Unmet Needs in the Treatment of HER2-Positive Breast Cancer

May 27th 2021

In the first segment, Dr Jhaveri and colleagues discuss the unmet needs clinicians face in the treatment of patients with HER2-positive breast cancer.

Treatment of Early-Stage HER2-Positive Breast Cancer

EP. 2: Treatment of Early-Stage HER2-Positive Breast Cancer

May 27th 2021

Dr Jhaveri and colleagues take an in-depth look at data from select clinical trials in the neoadjuvant and adjuvant settings for patients with HER2-positive breast cancer.

Treatment of Advanced HER2-Positive Breast Cancer

EP. 3: Treatment of Advanced HER2-Positive Breast Cancer

May 27th 2021

Dr Jhaveri and colleagues highlight key clinical trials in the setting of advanced HER2-positive breast cancer and discuss the practical considerations of these data.